February 16, 2023 — The American College of Cardiology (ACC) has announced five Late-Breaking Clinical Trial Sessions, two Late-Breaking Clinical Trial Deep Dive Sessions, and three Featured Clinical Research sessions will be presented during its annual scientific session, “ACC with WCC,” or ACC.23/WCC to be held March 4-6 in New Orleans, La.


February 16, 2023 — Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters, announced this week it has received FDA 510(k) clearance for reprocessing the

February 16, 2023 — Traffic noise may play an essential role in the development and deterioration of ischemic heart disease. Researchers from the Cardiology Department at the University Medical Center Mainz now discovered that noise exposure (average sound pressure level 72 dB; peak level 85 dB) up to 4d resulted in pro-inflammatory aortic gene expression in mice.


February 15, 2023 — The American College of Cardiology (ACC) will be joining with the World Heart Federation (WHF), in conjunction with the World Congress of Cardiology (WCC) for “ACC.23 Together with WCC,” to be held in New Orleans, La., March 4 – 6, 2023.


February 15, 2023 — Thrombolysis use increased from 4% in 2010 to 14% in 2020 in the traditionally underserved urban community of Flint, Michigan, at the conclusion of Stroke Ready, a community-wide trial to increase stroke thrombolysis in the predominantly

February 15, 2023 — Nano-X Imaging Ltd, an innovative medical imaging technology company, announced that its deep-learning medical imaging analytics subsidiary, Nanox.AI, has connected to the 

February 15, 2023 — Abbott and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.

February 14, 2023 — VST-Bio Corp. a leader in the development of innovative biologics to treat acute and chronic cardiovascular disease, presented data from a recent large animal study performed by VST-Bio and Yale University demonstrating that a sin

February 14, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced that positive results from the inspIRE company-sponsored

Subscribe Now